The Fund Grade · free · no account needed
What grade does GTLLX get?
Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.
Fundprints Fund Grade · as of 2026-10-01
Glenmede Disciplined U.S. Growth Equity Portfolio
#2 of 500 graded active funds · growth · mid segment peer group
The point · specialist footprint
GTLLX puts more of its book behind proven specialists than 69% of graded funds.
Bottom 20%
Bottom 40%
Middle
● Top 40%
Top 20%
That has mattered: over the past 2.7 years, funds on this rung beat bottom-rung funds by about 3.8% per quarter, and beat the S&P in 43% of fund-quarters versus their 22%. The evidence argues this fund earns its seat.
10,000+ funds tracked · the graded specialists among them drive every read
The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.
GTLLX vs the Honor Roll · share card ↗Conviction exposure
37.3%
of the book in specialist-converged names
Late-stage weight
16.7%
of the book in Crowded or Fading names
Active share
97.7%
how far it strays from the index
The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.
Inside the book: top names by stage · as of 2026-10-20
We email you the day it crosses 50% crowded, and where you stand every month.
Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.
The read · what to do with it
GTLLX ranks 2nd out of 500 graded funds, an A grade built on 37% specialist ownership. Specialists are early in Incyte and Jabil, which is where the real conviction sits right now. Watch the fading reads on Amphenol and TJX, both sizable positions where the same specialists are quietly stepping back.
→ Monitor Amphenol (3.1%) and TJX (2.6%) closely, as specialist exit signals in both positions are worth tracking.
→ Note the early specialist conviction in Incyte (2.6%) and Jabil (1.9%) as the clearest forward-looking evidence in this fund.
Support leaving these positions
Read from today's disclosed book. Evidence, not advice.